GURUR❤️💙🙏
Değerli Ağabeyim, Kalp ve Damar Cerrahı Prof. Dr. Ergun Demirsoy, Avrupa Kalp ve Damar Cerrahisi Derneği'nin (The European Society for Cardiovascular and Endovascular Surgery-ESCVS) gelecek dönem başkanı seçildi.
Ergun Demirsoy
.Joseph Betancourt says, “If you have two patients, all things equal about them except the color of their skin, who present to an emergency room… with chest pain… minorities are significantly less likely to be referred for cardiac catheterization, angioplasty, bypass surgery.”
Your lungs aren’t the only part of your body that will benefit from breathing #HealthyAir . There’s been a correlation found between air quality and brain function, child development, heart health, and more!
AprilAire has you covered with IAQ solutions. bit.ly/3KX6UCO
A new report by World Heart Federation shows cardiovascular disease deaths jumped globally from 12.1 million in 1990 to 20.5 million in 2021.
This made CVDs a leading cause of death with 4 in 5 occurring in low and middle-income countries.
#TransFatFreeEAC
#TransFatFreeKenya
FDA approval of colchicine for coronary inflammation is expected to have a big impact on cardiac care and outcomes. #colchicine #atherosclerosis #pharma #cardiotwitter #cardiology #pharma cology ow.ly/nAFo50OT8w8
Kalp ve Damar Cerrahı Prof. Dr. Ergun Demirsoy,Avrupa Kalp ve Damar Cerrahisi Derneği'nin (The European Society for Cardiovascular and Endovascular Surgery-ESCVS) gelecek dönem başkanı seçildi.
Sayın Ergun Demirsoy beyi tebrik ederim.👏👏
After winning the award for the Young Investigator in basic science #ERA23 , we will be pleased to welcome Christoph Kuppe, MD FASN next Wednesday (06/28) in our lab in Paris to give a talk about mutiomics in cardiovascular diseases! PARCC-INSERM